Market Cap
$842.1B
+2.4% today
Sector & Industry
Healthcare
Pharmaceuticals
SEC Filings
880
Total filings on record
Last Filing
Jan 19, 2026
8-K — Board of Directors Update
Showing 15 filings
| Form Type | Filed Date | Accepted | Description | Accession | Actions |
|---|---|---|---|---|---|
| DEF 14A | Jan 19, 2026 | Jan 19, 2026 | Definitive Proxy Statement for Annual Meeting | 0006900063-26-415507 | |
| 10-Q | Dec 27, 2025 | Dec 27, 2025 | Quarterly Report for period ended June 2025 | 0006900063-26-675299 | |
| 8-K | Dec 7, 2025 | Dec 7, 2025 | Current Report - Material Event Disclosure | 0006900063-26-767132 | |
| Form 4 | Oct 28, 2025 | Oct 28, 2025 | Statement of Changes - Linda Davis | 0006900063-26-742613 | |
| Form 4 | Oct 3, 2025 | Oct 3, 2025 | Statement of Changes - Michael Miller | 0006900063-26-622406 | |
| 13F | Sep 13, 2025 | Sep 13, 2025 | Institutional Investment Manager Holdings Report | 0006900063-26-406481 | |
| DEF 14A | Aug 17, 2025 | Aug 17, 2025 | Definitive Proxy Statement for Annual Meeting | 0006900063-26-675189 | |
| S-1 | Jul 14, 2025 | Jul 14, 2025 | Registration Statement | 0006900063-26-338952 | |
| 10-Q | Jun 9, 2025 | Jun 9, 2025 | Quarterly Report for period ended March 2025 | 0006900063-26-383925 | |
| S-1 | May 14, 2025 | May 14, 2025 | Registration Statement | 0006900063-26-656694 | |
| DEF 14A | Apr 21, 2025 | Apr 21, 2025 | Definitive Proxy Statement for Annual Meeting | 0006900063-25-320848 | |
| 8-K | Mar 19, 2025 | Mar 19, 2025 | Current Report - Material Event Disclosure | 0006900063-25-318421 | |
| 8-K | Feb 21, 2025 | Feb 21, 2025 | Current Report - Material Event Disclosure | 0006900063-25-842782 | |
| 8-K | Jan 24, 2025 | Jan 24, 2025 | Current Report - Material Event Disclosure | 0006900063-25-766024 | |
| 13F | Dec 24, 2024 | Dec 24, 2024 | Institutional Investment Manager Holdings Report | 0006900063-25-830901 |